Provider Resources WA

05/20/22 Health Advisory: CDC Recommends 5-11 year olds get a Pfizer COVID-19 Booster

three kids looking down at camera

Requested actions Be aware, the Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend children 5-11 years should get a COVID-19 vaccine booster dose five months after completion of the primary series of the Pfizer-BioNTech vaccine. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use … 05/20/22 Health Advisory: CDC Recommends 5-11 year olds get a Pfizer COVID-19 Booster

05/19/22 Health Advisory: Severe Hepatitis of Unknown Cause in Children

3 pairs of hands with paint on them

Actions Requested Be aware of severe cases of hepatitis in children that are occurring in the U.S. and worldwide. Consider adenovirus testing in pediatric patients with hepatitis of unknown cause (see preferred samples below). Report suspect cases in children to Whatcom County Health Department. A suspect case is a child with elevated AST or ALT … 05/19/22 Health Advisory: Severe Hepatitis of Unknown Cause in Children

05/16/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

Syringe drawing from a vial

Requested actions Be aware, on May 5, 2022, because of the risk of thrombosis with thrombocytopenia syndrome (TTS) after getting Johnson & Johnson COVID-19 vaccine (J&J), Food and Drug Administration (FDA) limited its authorized use to people 18 years or older: For whom other COVID-19 vaccines are not accessible or clinically appropriate. Who want only … 05/16/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

Syringe in vial

Requested actions Background FDA limited the authorized use of J&J to people age 18 years and older: This decision came after FDA analyzed, evaluated and investigated reported cases of TTS after getting J&J. TTS is rare and includes potentially life-threatening blood clots in combination with low levels of blood platelets. Symptoms typically start 1–2 weeks … 05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

Ariel shot of someone taking notes or completing paperwork

Requested Actions On April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use recommended antivirals … 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

Gloved hands holding a pipette in one and a test tube in another with beakers and microscope around.

Requested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email … 03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

03/01/2022 Provider Alert: UPDATE – COVID-19 Therapies

stethoscope sitting on laptop keyboard

Requested Actions Be aware, providers should contact and re-dose patients who previously received the 150mg Evushield dose (see below) Be Aware, supply of COVID-19 therapeutics is not currently limited in Whatcom County. While COVID-19 case rates are decreasing in Whatcom County, some patients may benefit from therapeutics. Decision to prescribe should be based on clinical … 03/01/2022 Provider Alert: UPDATE – COVID-19 Therapies

02/16/22 Health Advisory: CDC Updated COVID-19 Vaccination Guidelines, and More.

Two hands wearing surgical gloves holding syringe and drawing from a vial

Requested Actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster dose 3 months (instead … 02/16/22 Health Advisory: CDC Updated COVID-19 Vaccination Guidelines, and More.

02/02/22 Health Advisory: FDA Provides Full Approval For Spikevax

syringe in a vial

Requested Actions Be aware, U.S. Food and Drug Administration (FDA) granted full authorization to Moderna COVID-19 vaccine for people 18 years or older. Evidence shows the vaccine is safe and effective and manufactured with high quality. The vaccine will now be called Spikevax but has the same formulation as emergency use authorization (EUA) Moderna COVID-19 … 02/02/22 Health Advisory: FDA Provides Full Approval For Spikevax

01/08/22 Health Advisory: CDC updated Antiviral Guidance; Booster Eligibility Expanded

tongue depressors and cotton swabs on physician's desk

COVID-19 Updates for Providers Requested actions Updated Antiviral Guidance Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit … 01/08/22 Health Advisory: CDC updated Antiviral Guidance; Booster Eligibility Expanded